GPT Healthcare Limited
Financial Performance Highlights
Q2 FY27 Performance:
- Total Revenue: ₹138.6 crore, up 15.2% YoY from ₹120.2 crore in Q2 FY26
- Revenue from Operations: ₹135.6 crore
- Other Operating Income: ₹2.9 crore
- EBITDA: ₹29.8 crore, up 23.9% YoY
- EBITDA Margin: 21.5% (vs 20.0% in Q2 FY26)
- EBIT: ₹22.8 crore, up 32.2% YoY
- EBIT Margin: 16.4% (vs 14.3% in Q2 FY26)
- Profit Before Tax: ₹20.7 crore, up 37.2% YoY
- PBT Margin: 14.9% (vs 12.5% in Q2 FY26)
- Profit After Tax: ₹15.4 crore, up 45.2% YoY
- PAT Margin: 11.1% (vs 8.8% in Q2 FY26)
- EPS (Basic): ₹1.9
H1 FY27 Performance:
- Total Revenue: ₹266.8 crore, up 16.5% YoY from ₹228.9 crore in H1 FY26
- Revenue from Operations: ₹261.8 crore
- Other Operating Income: ₹5.0 crore
- EBITDA: ₹56.0 crore, up 30.3% YoY
- EBITDA Margin: 21.0% (vs 18.8% in H1 FY26)
- EBIT: ₹42.1 crore, up 40.4% YoY
- EBIT Margin: 15.8% (vs 13.1% in H1 FY26)
- Profit Before Tax: ₹37.8 crore, up 44.5% YoY
- PBT Margin: 14.2% (vs 11.4% in H1 FY26)
- Profit After Tax: ₹28.1 crore, up 53.9% YoY
- PAT Margin: 10.5% (vs 8.0% in H1 FY26)
- EPS (Basic): ₹3.4
Operational Metrics
Key Operational Highlights:
- ARPOB grew 7.1% YoY to ₹40,721
- Network occupancy improved to 50.3% in Q2FY27 from 47.4% previously (59.8% excluding Raipur)
- Mature hospitals contributed ₹261.8 crore revenue, ₹56.0 crore EBITDA, and ₹28.1 crore PAT in H1FY27
- EBITDA margin for mature hospitals approximately 21%
Hospital-wise Performance Q2 & H1 FY27:
| Hospital | Year Commissioned | Bed Capacity | Q2 Revenue (₹Cr) | H1 Revenue (₹Cr) | Q2 Occupancy | H1 Occupancy | Q2 ARPOB (₹) | H1 ARPOB (₹) |
| ILS Salt Lake | 2000 | 85 | 22.2 | 44.0 | 68.4% | 65.4% | 41,480 | 43,284 |
| ILS Agartala | 2011 | 205 | 39.7 | 74.8 | 53.7% | 49.6% | 39,154 | 40,254 |
| ILS Dum Dum | 2013 | 155 | 45.1 | 84.8 | 73.3% | 69.4% | 43,125 | 43,086 |
| ILS Howrah | 2019 | 116 | 19.7 | 38.5 | 46.4% | 45.8% | 39,672 | 39,556 |
| ILS Raipur | 2025 | 158 | 9.0 | 19.6 | 16.5% | 17.0% | 37,347 | 39,885 |
Clinical and Operational Developments
ILS Raipur:
- Achieved NABH accreditation within first year of operation
- Performed first TAVI procedure and liver transplant in Q2 FY27
- Completed 11 renal transplants within a year
ILS Agartala:
- Oncology program performed over 3,200 radiation therapy procedures through Linear Accelerator facility
- Completed over 1,000 PET scans in just over a year
- Only private hospital in Tripura accredited by both NABH and NABL
ILS Salt Lake:
- Crossed 850 robotic surgeries
- 85-bed tertiary surgical hospital with 17 ICUs and 3 OTs
- NBE-accredited Minimal Access Surgery department
ILS Howrah:
- Equipped with MAKO robotic system, nearing 100 robotic procedures
- Emergency services upgraded from 2 to 10 beds
- Achieved EBITDA breakeven within 8 months of inauguration
Expansion Plans and Capital Allocation
Jamshedpur Hospital:
- 155-bed tertiary care hospital
- ₹75 crore investment
- Expected commissioning in March/April 2027
- Land and building funded by developers with fixed rental arrangements
Future Expansion:
- Targeting Tier II cities (Uttar Pradesh, Assam, Odisha) and select Tier I locations in Eastern India
- Plan to scale to 1,000-bed network by FY2027
- Targeting long-term ROCE and ROE of approximately 25%
Balance Sheet Position (H1FY27)
Assets:
- Property, plant and equipment: ₹264.8 crore
- Capital WIP: ₹8.1 crore
- Other Non-current Assets: ₹103.8 crore
- Total Non-current Assets: ₹376.6 crore
- Inventories: ₹11.6 crore
- Debtors: ₹31.6 crore
- Cash Equivalents & Bank: ₹1.2 crore
- Investments: ₹45.5 crore
- Total Current Assets: ₹103.4 crore
- Total Assets: ₹480.1 crore
Liabilities and Equity:
- Share Capital: ₹82.1 crore
- Other Equity: ₹203.1 crore
- Total Equity: ₹285.2 crore
- Borrowings (Non-current): ₹2.7 crore
- Lease Liabilities: ₹69.5 crore
- Total Non-current Liabilities: ₹112.4 crore
- Borrowings (Current): ₹12.2 crore
- Trade Payables: ₹43.7 crore
- Total Current Liabilities: ₹82.4 crore
- Total Liabilities: ₹194.9 crore
Cash Flow Statement (H1FY27)
- Profit before Tax: ₹37.8 crore
- Net Cash from Operating Activities: ₹34.2 crore
- Cash Flow from Investing Activities: -₹16.5 crore
- Cash Flow from Financing Activities: -₹21.0 crore
- Net decrease in Cash & Cash equivalent: -₹3.2 crore
- Cash and cash equivalents as at September 30, 2026: ₹0.9 crore
Technology Initiatives
- SPARSH home healthcare service for senior citizens at ₹500 annual fee
- User-friendly mobile application for appointment booking and medical records
- Hospital Management Information System for digital medical records
- 750+ robotic surgeries performed across facilities
Leadership and Governance
- Led by Dr. Om Tantia
- Board of Directors with professional and experienced leadership
- Company Secretary and Compliance Officer: Ankur Sharma (M. No A31833)
Investor Relations
- Investor Relations Advisors: Cygnus Partners Private Limited
- Contacts: Ms. Pooja Swami, Ms. Mamta Nehra